UNSPSC 85531318: Replacement of lower vein with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of lower vein with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06RY47Z

UNSPSC 85531318 Replacement of lower vein with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that, based on recent state and local solicitation activity, shows minimal alignment with its clinical descriptor. The code does not map cleanly to the work actually being procured in the available opportunities. Instead, recent solicitations tagged under this code reflect administrative medical services, pharmacy and health benefit management, occupational health surveillance, and temporary clinical staffing — none of which involve surgical vein replacement procedures. The issuing bodies span city retirement systems, county health systems and human resources divisions, state transportation departments, and county juvenile justice agencies, reflecting the broad reach of public-sector health administration and benefits procurement rather than a specialized surgical service line.

The recent opportunities cluster across Arizona (City of Phoenix Retirement Office's independent medical evaluation services RFP due October 16, 2026), California (City of Long Beach surgical benefit carve-out RFP due October 7, 2026; County of Santa Clara Health System temporary health professional staffing due October 7, 2026), Washington (Washington State Department of Transportation occupational medical surveillance due October 9, 2026), Florida (Collier County pharmacy benefit management RFP originally due April 9, 2026), and Texas (Harris County Juvenile Probation Department emergency medical services RFI due September 25, 2026). Given the mismatch between the code's nominal scope and the substantive work in these solicitations, this Commodity code shows little relevant recent activity for firms pursuing opportunities in vein replacement or comparable surgical procedures.